Author

M. Cristofanilli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:experimental assay· 3 Assay:proteomics· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Y. Zhang· 3 shared C. Reduzzi· 2 shared C.-F. Tsai· 2 shared D. Scholten· 2 shared E. J. Schuster· 2 shared E. K. Ramos· 2 shared H. Liu· 2 shared L. El-Shennawy· 2 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Y. Zhang

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

NF1 modulates microtubule repair and sensitivity to antibody-drug conjugates

B. Achutti Duso, E. Messuti, G. Tini, E. Bonetti, A. Castiglioni, G. Frige, G. Ciossani, S. Monzani, C. Soriani, D. Khuntsariya, N. Roda, A. Polazzi, M. R. Ippolito, E. Gavilan Dorronzoro, E. Mane, , L. Mazzarella

This study shows that NF1 loss increases sensitivity to the ADC T-DM1 by modulating microtubule repair and dynamics, identifying NF1 as a predictive biomarker for ADC response.

bioRxiv · Dec 6, 2023 · PreprintCancer Biology

Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis

E. J. Schuster, N. K. Dashzeveg, Y. Jia, K. Golam, T. Zhang, A. D. Hoffman, Y. Zhang, C. Zheng, E. K. Ramos, R. Taftaf, L. El-Shennawy, D. Scholten, V. Adorno-Cruz, C. Reduzzi, R. Xu, , S. Spahija

This study identifies Plexin-B2 as a driver of homotypic and heterotypic CTC clusters in breast cancer metastasis, with high expression linked to poor prognosis and therapeutic potential.

bioRxiv · Apr 10, 2023 · PreprintCancer Biology

CD81 partners with CD44 in promoting exosome biogenesis, tumor cluster formation, and lung metastasis in triple negative breast cancer

E. K. Ramos, C.-F. Tsai, N. K. Dashzeveg, Y. Jia, Y. Cao, M. Manu, R. Taftaf, A. D. Hoffmann, L. El-Shennawy, M. A. Gritsenko, V. Adorno-Cruz, E. J. Schuster, D. Scholten, D. Patel, X. Liu, , H. Liu

bioRxiv · Feb 23, 2022Cancer Biology

Hotspot ESR1 mutations are multimodal and contextual drivers of breast cancer metastasis

Z. Li, Y. Wu, M. E. Yates, N. Tasdemir, A. Bahreini, J. Chen, K. M. Levine, N. M. Priedigkeit, S. Ali, L. Buluwela, S. Arnesen, J. Gertz, J. K. Richer, B. Troness, D. El-Ashry, , S. Oesterreich

This study identifies ESR1 mutations as drivers of breast cancer metastasis by altering cell adhesion and migration through genomic and transcriptomic reprogramming.

bioRxiv · Feb 10, 2021 · PreprintCancer Biology